nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—Methamphetamine—Lacosamide—epilepsy syndrome	0.205	1	CrCrCtD
Dexfenfluramine—SLC6A4—epilepsy syndrome	0.111	0.377	CbGaD
Dexfenfluramine—CYP2C19—epilepsy syndrome	0.105	0.358	CbGaD
Dexfenfluramine—CYP2D6—epilepsy syndrome	0.078	0.265	CbGaD
Dexfenfluramine—CYP2A6—Amobarbital—epilepsy syndrome	0.0243	0.0563	CbGbCtD
Dexfenfluramine—CYP2E1—Trimethadione—epilepsy syndrome	0.0212	0.049	CbGbCtD
Dexfenfluramine—CYP2E1—Felbamate—epilepsy syndrome	0.0212	0.049	CbGbCtD
Dexfenfluramine—CYP2A6—Propofol—epilepsy syndrome	0.0182	0.0419	CbGbCtD
Dexfenfluramine—CYP2E1—Clonazepam—epilepsy syndrome	0.018	0.0417	CbGbCtD
Dexfenfluramine—CYP2A6—Phenobarbital—epilepsy syndrome	0.0173	0.0401	CbGbCtD
Dexfenfluramine—CYP2E1—Rufinamide—epilepsy syndrome	0.0147	0.034	CbGbCtD
Dexfenfluramine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0143	0.033	CbGbCtD
Dexfenfluramine—CYP2C19—Felbamate—epilepsy syndrome	0.0133	0.0307	CbGbCtD
Dexfenfluramine—CYP2C19—Trimethadione—epilepsy syndrome	0.0133	0.0307	CbGbCtD
Dexfenfluramine—CYP2A6—Valproic Acid—epilepsy syndrome	0.013	0.03	CbGbCtD
Dexfenfluramine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0125	0.0289	CbGbCtD
Dexfenfluramine—CYP2E1—Propofol—epilepsy syndrome	0.012	0.0277	CbGbCtD
Dexfenfluramine—CYP2E1—Phenobarbital—epilepsy syndrome	0.0114	0.0265	CbGbCtD
Dexfenfluramine—CYP2E1—Midazolam—epilepsy syndrome	0.0113	0.0261	CbGbCtD
Dexfenfluramine—CYP2C9—Trimethadione—epilepsy syndrome	0.011	0.0255	CbGbCtD
Dexfenfluramine—CYP2E1—Diazepam—epilepsy syndrome	0.0109	0.0251	CbGbCtD
Dexfenfluramine—CYP2C19—Clobazam—epilepsy syndrome	0.0108	0.025	CbGbCtD
Dexfenfluramine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0104	0.024	CbGbCtD
Dexfenfluramine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00898	0.0207	CbGbCtD
Dexfenfluramine—CYP2C19—Primidone—epilepsy syndrome	0.00838	0.0194	CbGbCtD
Dexfenfluramine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00828	0.0191	CbGbCtD
Dexfenfluramine—CYP2C19—Phenytoin—epilepsy syndrome	0.00805	0.0186	CbGbCtD
Dexfenfluramine—CYP1A2—Primidone—epilepsy syndrome	0.00773	0.0179	CbGbCtD
Dexfenfluramine—CYP2C19—Propofol—epilepsy syndrome	0.00751	0.0174	CbGbCtD
Dexfenfluramine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00746	0.0172	CbGbCtD
Dexfenfluramine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00718	0.0166	CbGbCtD
Dexfenfluramine—CYP2C9—Primidone—epilepsy syndrome	0.00697	0.0161	CbGbCtD
Dexfenfluramine—CYP1A2—Propofol—epilepsy syndrome	0.00693	0.016	CbGbCtD
Dexfenfluramine—CYP2C19—Diazepam—epilepsy syndrome	0.0068	0.0157	CbGbCtD
Dexfenfluramine—CYP2C9—Phenytoin—epilepsy syndrome	0.00669	0.0155	CbGbCtD
Dexfenfluramine—CYP2C19—Zonisamide—epilepsy syndrome	0.00664	0.0153	CbGbCtD
Dexfenfluramine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00662	0.0153	CbGbCtD
Dexfenfluramine—CYP1A2—Diazepam—epilepsy syndrome	0.00628	0.0145	CbGbCtD
Dexfenfluramine—CYP2C9—Propofol—epilepsy syndrome	0.00624	0.0144	CbGbCtD
Dexfenfluramine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00597	0.0138	CbGbCtD
Dexfenfluramine—CYP2D6—Propofol—epilepsy syndrome	0.00571	0.0132	CbGbCtD
Dexfenfluramine—CYP2C9—Diazepam—epilepsy syndrome	0.00566	0.0131	CbGbCtD
Dexfenfluramine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00536	0.0124	CbGbCtD
Dexfenfluramine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00495	0.0114	CbGbCtD
Dexfenfluramine—CYP2C19—Topiramate—epilepsy syndrome	0.00484	0.0112	CbGbCtD
Dexfenfluramine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00446	0.0103	CbGbCtD
Dexfenfluramine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00176	0.112	CbGeAlD
Dexfenfluramine—HTR2C—ganglion—epilepsy syndrome	0.0011	0.0697	CbGeAlD
Dexfenfluramine—SLC6A4—ganglion—epilepsy syndrome	0.00104	0.066	CbGeAlD
Dexfenfluramine—SLC6A4—hindbrain—epilepsy syndrome	0.000789	0.0501	CbGeAlD
Dexfenfluramine—HTR2C—brainstem—epilepsy syndrome	0.000477	0.0303	CbGeAlD
Dexfenfluramine—HTR2C—forebrain—epilepsy syndrome	0.00046	0.0292	CbGeAlD
Dexfenfluramine—SLC6A4—brainstem—epilepsy syndrome	0.000452	0.0287	CbGeAlD
Dexfenfluramine—SLC6A4—forebrain—epilepsy syndrome	0.000436	0.0277	CbGeAlD
Dexfenfluramine—HTR2B—forebrain—epilepsy syndrome	0.000432	0.0274	CbGeAlD
Dexfenfluramine—HTR2C—telencephalon—epilepsy syndrome	0.000423	0.0269	CbGeAlD
Dexfenfluramine—SLC6A4—telencephalon—epilepsy syndrome	0.000401	0.0255	CbGeAlD
Dexfenfluramine—HTR2B—telencephalon—epilepsy syndrome	0.000397	0.0252	CbGeAlD
Dexfenfluramine—CYP2D6—hindbrain—epilepsy syndrome	0.00038	0.0241	CbGeAlD
Dexfenfluramine—HTR2C—medulla oblongata—epilepsy syndrome	0.000332	0.0211	CbGeAlD
Dexfenfluramine—HTR2C—midbrain—epilepsy syndrome	0.000304	0.0193	CbGeAlD
Dexfenfluramine—HTR2C—spinal cord—epilepsy syndrome	0.000296	0.0188	CbGeAlD
Dexfenfluramine—SLC6A4—midbrain—epilepsy syndrome	0.000288	0.0183	CbGeAlD
Dexfenfluramine—CYP2A6—cerebellum—epilepsy syndrome	0.000287	0.0182	CbGeAlD
Dexfenfluramine—SLC6A4—spinal cord—epilepsy syndrome	0.000281	0.0178	CbGeAlD
Dexfenfluramine—HTR2C—head—epilepsy syndrome	0.000263	0.0167	CbGeAlD
Dexfenfluramine—Cinacalcet—CYP2D6—epilepsy syndrome	0.000257	0.359	CrCbGaD
Dexfenfluramine—HTR2C—nervous system—epilepsy syndrome	0.00025	0.0159	CbGeAlD
Dexfenfluramine—SLC6A4—head—epilepsy syndrome	0.00025	0.0159	CbGeAlD
Dexfenfluramine—HTR2B—head—epilepsy syndrome	0.000248	0.0157	CbGeAlD
Dexfenfluramine—CYP2E1—telencephalon—epilepsy syndrome	0.000244	0.0155	CbGeAlD
Dexfenfluramine—HTR2C—central nervous system—epilepsy syndrome	0.00024	0.0153	CbGeAlD
Dexfenfluramine—SLC6A4—nervous system—epilepsy syndrome	0.000237	0.015	CbGeAlD
Dexfenfluramine—HTR2B—nervous system—epilepsy syndrome	0.000235	0.0149	CbGeAlD
Dexfenfluramine—CYP2A6—brain—epilepsy syndrome	0.000233	0.0148	CbGeAlD
Dexfenfluramine—SLC6A4—central nervous system—epilepsy syndrome	0.000228	0.0145	CbGeAlD
Dexfenfluramine—HTR2B—central nervous system—epilepsy syndrome	0.000226	0.0143	CbGeAlD
Dexfenfluramine—CYP2D6—brainstem—epilepsy syndrome	0.000218	0.0138	CbGeAlD
Dexfenfluramine—CYP2D6—forebrain—epilepsy syndrome	0.00021	0.0134	CbGeAlD
Dexfenfluramine—Methamphetamine—ADRA2A—epilepsy syndrome	0.0002	0.279	CrCbGaD
Dexfenfluramine—CYP2D6—telencephalon—epilepsy syndrome	0.000193	0.0123	CbGeAlD
Dexfenfluramine—CYP2E1—medulla oblongata—epilepsy syndrome	0.000192	0.0122	CbGeAlD
Dexfenfluramine—HTR2C—brain—epilepsy syndrome	0.000191	0.0121	CbGeAlD
Dexfenfluramine—SLC6A4—brain—epilepsy syndrome	0.000181	0.0115	CbGeAlD
Dexfenfluramine—HTR2B—brain—epilepsy syndrome	0.000179	0.0114	CbGeAlD
Dexfenfluramine—CYP2E1—spinal cord—epilepsy syndrome	0.000171	0.0109	CbGeAlD
Dexfenfluramine—Methamphetamine—SLC6A4—epilepsy syndrome	0.000153	0.213	CrCbGaD
Dexfenfluramine—CYP2E1—head—epilepsy syndrome	0.000152	0.00966	CbGeAlD
Dexfenfluramine—CYP2E1—nervous system—epilepsy syndrome	0.000144	0.00916	CbGeAlD
Dexfenfluramine—CYP2E1—central nervous system—epilepsy syndrome	0.000139	0.00881	CbGeAlD
Dexfenfluramine—CYP2E1—cerebellum—epilepsy syndrome	0.000136	0.00862	CbGeAlD
Dexfenfluramine—CYP2D6—head—epilepsy syndrome	0.00012	0.00765	CbGeAlD
Dexfenfluramine—CYP2D6—nervous system—epilepsy syndrome	0.000114	0.00725	CbGeAlD
Dexfenfluramine—CYP2E1—brain—epilepsy syndrome	0.00011	0.007	CbGeAlD
Dexfenfluramine—CYP2D6—central nervous system—epilepsy syndrome	0.00011	0.00698	CbGeAlD
Dexfenfluramine—CYP2D6—cerebellum—epilepsy syndrome	0.000107	0.00682	CbGeAlD
Dexfenfluramine—Methamphetamine—CYP2D6—epilepsy syndrome	0.000107	0.15	CrCbGaD
Dexfenfluramine—CYP2D6—brain—epilepsy syndrome	8.73e-05	0.00554	CbGeAlD
Dexfenfluramine—HTR2C—Signaling Pathways—OXT—epilepsy syndrome	6.29e-06	0.000122	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.27e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.26e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	6.25e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.22e-06	0.00012	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCR5—epilepsy syndrome	6.21e-06	0.00012	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HBEGF—epilepsy syndrome	6.17e-06	0.000119	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.16e-06	0.000119	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	6.12e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.1e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—BCHE—epilepsy syndrome	6.09e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	6.08e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.08e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR2A—epilepsy syndrome	6.08e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT3—epilepsy syndrome	6.05e-06	0.000117	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—POMC—epilepsy syndrome	6.02e-06	0.000116	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NT5E—epilepsy syndrome	5.92e-06	0.000115	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALAD—epilepsy syndrome	5.92e-06	0.000115	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ADAM10—epilepsy syndrome	5.91e-06	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCL2—epilepsy syndrome	5.89e-06	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.87e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TSC1—epilepsy syndrome	5.85e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTK2B—epilepsy syndrome	5.85e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.84e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	5.81e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.81e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AGT—epilepsy syndrome	5.77e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.76e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	5.75e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—TH—epilepsy syndrome	5.73e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.71e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCR2—epilepsy syndrome	5.69e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NTRK2—epilepsy syndrome	5.69e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SST—epilepsy syndrome	5.69e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	5.66e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	5.65e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	5.65e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DUSP6—epilepsy syndrome	5.64e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	5.63e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—S100B—epilepsy syndrome	5.59e-06	0.000108	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.59e-06	0.000108	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ADRA2A—epilepsy syndrome	5.57e-06	0.000108	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PLAT—epilepsy syndrome	5.55e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.54e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SOCS3—epilepsy syndrome	5.54e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.53e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDC42—epilepsy syndrome	5.52e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.5e-06	0.000106	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.5e-06	0.000106	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.42e-06	0.000105	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL12—epilepsy syndrome	5.35e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—BDKRB2—epilepsy syndrome	5.35e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AVP—epilepsy syndrome	5.35e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—POMC—epilepsy syndrome	5.34e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PRKCB—epilepsy syndrome	5.33e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.32e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.31e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6ST—epilepsy syndrome	5.31e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CNR1—epilepsy syndrome	5.25e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JUNB—epilepsy syndrome	5.25e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PLCB1—epilepsy syndrome	5.23e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.22e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR7—epilepsy syndrome	5.13e-06	9.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.12e-06	9.9e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	5.08e-06	9.82e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HES1—epilepsy syndrome	5.06e-06	9.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.06e-06	9.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.06e-06	9.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.02e-06	9.7e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.01e-06	9.69e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.01e-06	9.69e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HBEGF—epilepsy syndrome	4.98e-06	9.62e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FYN—epilepsy syndrome	4.92e-06	9.51e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—H2AFX—epilepsy syndrome	4.9e-06	9.47e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MEF2C—epilepsy syndrome	4.89e-06	9.46e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT3—epilepsy syndrome	4.88e-06	9.44e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	4.88e-06	9.43e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—POMC—epilepsy syndrome	4.85e-06	9.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.83e-06	9.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.81e-06	9.31e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	4.78e-06	9.24e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ADAM10—epilepsy syndrome	4.77e-06	9.22e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCL2—epilepsy syndrome	4.75e-06	9.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	4.74e-06	9.16e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—YWHAZ—epilepsy syndrome	4.73e-06	9.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CAT—epilepsy syndrome	4.72e-06	9.12e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NGF—epilepsy syndrome	4.67e-06	9.04e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.67e-06	9.03e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	4.59e-06	8.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	4.59e-06	8.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.57e-06	8.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.55e-06	8.8e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	4.55e-06	8.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	4.54e-06	8.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—TH—epilepsy syndrome	4.52e-06	8.75e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—S100B—epilepsy syndrome	4.51e-06	8.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.48e-06	8.67e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SOCS3—epilepsy syndrome	4.47e-06	8.64e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDC42—epilepsy syndrome	4.46e-06	8.62e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	4.45e-06	8.6e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.34e-06	8.39e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	4.31e-06	8.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.31e-06	8.33e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.28e-06	8.28e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.28e-06	8.28e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	4.26e-06	8.25e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	4.23e-06	8.17e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	4.22e-06	8.16e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	4.14e-06	8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.12e-06	7.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.09e-06	7.9e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	4.08e-06	7.89e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	4.05e-06	7.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.02e-06	7.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.99e-06	7.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.99e-06	7.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.98e-06	7.7e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	3.97e-06	7.67e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.96e-06	7.65e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	3.95e-06	7.64e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	3.95e-06	7.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.93e-06	7.6e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.93e-06	7.6e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.92e-06	7.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.91e-06	7.56e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	3.9e-06	7.54e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	3.89e-06	7.51e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	3.81e-06	7.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.78e-06	7.3e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	3.77e-06	7.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AGT—epilepsy syndrome	3.74e-06	7.23e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.73e-06	7.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.73e-06	7.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.71e-06	7.18e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	3.67e-06	7.09e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APOE—epilepsy syndrome	3.66e-06	7.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.62e-06	7.01e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	3.59e-06	6.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.58e-06	6.93e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.57e-06	6.91e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	3.55e-06	6.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.54e-06	6.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.5e-06	6.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.49e-06	6.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TH—epilepsy syndrome	3.49e-06	6.75e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	3.48e-06	6.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.44e-06	6.65e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.43e-06	6.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.42e-06	6.6e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	3.41e-06	6.59e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	3.41e-06	6.59e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.4e-06	6.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.4e-06	6.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.39e-06	6.55e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.38e-06	6.54e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	3.37e-06	6.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.36e-06	6.49e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	3.34e-06	6.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	3.27e-06	6.32e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.26e-06	6.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.23e-06	6.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.22e-06	6.23e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TH—epilepsy syndrome	3.21e-06	6.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.19e-06	6.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TH—epilepsy syndrome	3.18e-06	6.16e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—POMC—epilepsy syndrome	3.15e-06	6.09e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	3.15e-06	6.09e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	3.14e-06	6.08e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	3.13e-06	6.06e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.13e-06	6.06e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.06e-06	5.92e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.05e-06	5.9e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AGT—epilepsy syndrome	2.95e-06	5.71e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	2.92e-06	5.64e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.91e-06	5.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.91e-06	5.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.9e-06	5.6e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.89e-06	5.59e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.87e-06	5.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALB—epilepsy syndrome	2.87e-06	5.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	2.87e-06	5.54e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	2.86e-06	5.53e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	2.8e-06	5.42e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.8e-06	5.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.76e-06	5.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.73e-06	5.28e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TH—epilepsy syndrome	2.72e-06	5.26e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.68e-06	5.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.68e-06	5.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.66e-06	5.14e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.66e-06	5.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.64e-06	5.11e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	2.63e-06	5.09e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.62e-06	5.07e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.6e-06	5.03e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.57e-06	4.97e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	2.56e-06	4.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.55e-06	4.93e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	2.53e-06	4.9e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	2.51e-06	4.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.49e-06	4.81e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	2.49e-06	4.81e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.41e-06	4.66e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.39e-06	4.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.37e-06	4.58e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	2.35e-06	4.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	2.31e-06	4.46e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	2.29e-06	4.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.28e-06	4.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.27e-06	4.39e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.27e-06	4.39e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.24e-06	4.33e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.23e-06	4.32e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.23e-06	4.32e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.18e-06	4.21e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.14e-06	4.14e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	2.12e-06	4.1e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.1e-06	4.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.08e-06	4.02e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	2.06e-06	3.99e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.05e-06	3.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.04e-06	3.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.03e-06	3.92e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	2.01e-06	3.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.98e-06	3.84e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.95e-06	3.76e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.92e-06	3.71e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	1.85e-06	3.58e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.8e-06	3.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.78e-06	3.44e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.76e-06	3.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.75e-06	3.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.75e-06	3.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.74e-06	3.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.61e-06	3.11e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.6e-06	3.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	2.96e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.5e-06	2.89e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-06	2.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.41e-06	2.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.4e-06	2.7e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.36e-06	2.64e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	1.26e-06	2.44e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.19e-06	2.31e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.15e-06	2.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	9.97e-07	1.93e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.69e-07	1.49e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.08e-07	1.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.01e-07	1.36e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	5.99e-07	1.16e-05	CbGpPWpGaD
